packageCabozantinib

cabozantinib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Cabozantinib is a protein kinase inhibitor used to treat cancers such as renal cell carcinoma and medullary thyroid cancer. It is authorised in the European Union for thyroid, kidney, and liver cancers and is used in cancer care.

Summary written by glm-5.3-flash from Wikidata Q795057 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:cabozantinib
ATC codes:L01EX07, L01XE
DrugBank:DB08875
PubChem CID:25102847
ChEBI:72317
Wikidata:Q795057
formula:C28H24FN3O5
molar mass:501.514 g/mol (PubChem CID 25102847)
logP:5.4 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown